5-10
2026
影响因子区间
—
平台估算
71%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology.Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.
【译文】当前分子药理学致力于发表细胞和分子药学的最新进展,重点关注正在开发的创新药物的作用机制、创新药理学技术、细胞信号传导、转导途径分析、基因组学、蛋白质组学和代谢组学在药物作用中的应用。此外,该期刊还将关注正常生物学功能如何通过了解药物在细胞和分子水平上的作用得到阐明。该期刊发表关于分子药学的全文/迷你综述、原创研究文章和专题问题。Current Molecular Pharmacology是每个参与药物设计和发现、靶点鉴定、靶点验证、药物治疗性开发的研究人员不可或缺的期刊。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |